Search Results - "SUGAYA, M"

Refine Results
  1. 1

    Search for the best biologic for psoriasis by Sugaya, M.

    Published in British journal of dermatology (1951) (01-09-2021)
    “…Linked Article: Tollenaere et al. Br J Dermatol 2021; 185:585–594…”
    Get full text
    Journal Article
  2. 2

    MicroRNA-16 mediates the regulation of a senescence–apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas by Kitadate, A, Ikeda, S, Teshima, K, Ito, M, Toyota, I, Hasunuma, N, Takahashi, N, Miyagaki, T, Sugaya, M, Tagawa, H

    Published in Oncogene (14-07-2016)
    “…Multiple sequential genetic and epigenetic alterations underlie cancer development and progression. Overcoming cellular senescence is an early step in cancer…”
    Get full text
    Journal Article
  3. 3
  4. 4

    A potential contribution of antimicrobial peptide LL-37 to tissue fibrosis and vasculopathy in systemic sclerosis by Takahashi, T., Asano, Y., Nakamura, K., Yamashita, T., Saigusa, R., Ichimura, Y., Toyama, T., Taniguchi, T., Yoshizaki, A., Tamaki, Z., Tada, Y., Sugaya, M., Kadono, T., Sato, S.

    Published in British journal of dermatology (1951) (01-12-2016)
    “…Summary Background LL‐37 is an antimicrobial peptide with pleiotropic effects on the immune system, angiogenesis and tissue remodelling. These are cardinal…”
    Get full text
    Journal Article
  5. 5

    Fli1 deficiency contributes to the downregulation of endothelial protein C receptor in systemic sclerosis: a possible role in prothrombotic conditions by Saigusa, R., Asano, Y., Yamashita, T., Taniguchi, T., Takahashi, T., Ichimura, Y., Toyama, T., Yoshizaki, A., Miyagaki, T., Sugaya, M., Sato, S.

    Published in British journal of dermatology (1951) (01-02-2016)
    “…Summary Background Endothelial protein C receptor (EPCR), expressed predominantly on endothelial cells, plays a critical role in the regulation of the…”
    Get full text
    Journal Article
  6. 6
  7. 7

    A possible contribution of lipocalin-2 to the development of dermal fibrosis, pulmonary vascular involvement and renal dysfunction in systemic sclerosis by Takahashi, T., Asano, Y., Noda, S., Aozasa, N., Akamata, K., Taniguchi, T., Ichimura, Y., Toyama, T., Sumida, H., Kuwano, Y., Tada, Y., Sugaya, M., Kadono, T., Sato, S.

    Published in British journal of dermatology (1951) (01-09-2015)
    “…Summary Background Lipocalin‐2 is an adipocytokine implicated in apoptosis, innate immunity, angiogenesis, and the development of chronic kidney disease…”
    Get full text
    Journal Article
  8. 8

    Interleukin‐25 is involved in cutaneous T‐cell lymphoma progression by establishing a T helper 2‐dominant microenvironment by Nakajima, R., Miyagaki, T., Hirakawa, M., Oka, T., Takahashi, N., Suga, H., Yoshizaki, A., Fujita, H., Asano, Y., Sugaya, M., Sato, S.

    Published in British journal of dermatology (1951) (01-06-2018)
    “…Summary Background Interleukin (IL)‐25 is a member of the IL‐17 family, which can promote and augment T‐helper (Th) type 2 responses. The expression of IL‐25…”
    Get full text
    Journal Article
  9. 9

    Serum IL-33 levels are increased in patients with psoriasis by Mitsui, A., Tada, Y., Takahashi, T., Shibata, S., Kamata, M., Miyagaki, T., Fujita, H., Sugaya, M., Kadono, T., Sato, S., Asano, Y.

    Published in Clinical and experimental dermatology (01-03-2016)
    “…Summary Background Interleukin (IL)‐33 is a recently identified cytokine, which is a member of the IL‐1 family and binds to a heterodimeric receptor comprising…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Increased CCL18 expression in patients with cutaneous T-cell lymphoma: association with disease severity and prognosis by Miyagaki, T., Sugaya, M., Suga, H., Ohmatsu, H., Fujita, H., Asano, Y., Tada, Y., Kadono, T., Sato, S.

    “…Background  CC chemokine ligand (CCL) 18 is expressed by monocytes and dendritic cells (DCs), and has potent chemotactic activity for T cells, B cells and DCs…”
    Get full text
    Journal Article
  13. 13

    Expression of CCR3 and CCR4 Suggests a Poor Prognosis in Mycosis Fungoides and Sézary Syndrome by Shono, Yuki, Suga, Hiraku, Kamijo, Hiroaki, Fujii, Hikari, Oka, Tomonori, Miyagaki, Tomomitsu, Shishido-Takahashi, Naomi, Sugaya, Makoto, Sato, Shinichi

    Published in Acta dermato-venereologica (01-07-2019)
    “…Tumor cells in cutaneous T-cell lymphoma express limited numbers of chemokine receptors. We investigated the expression patterns of CXCR3, CCR3, CCR4 and CCR10…”
    Get full text
    Journal Article
  14. 14
  15. 15

    FDG-PET in T-cell and NK-cell neoplasms by Kako, S., Izutsu, K., Ota, Y., Minatani, Y., Sugaya, M., Momose, T., Ohtomo, K., Kanda, Y., Chiba, S., Motokura, T., Kurokawa, M.

    Published in Annals of oncology (01-10-2007)
    “…Background: A growing number of studies demonstrate the utility of 18fluoro-2-deoxyglucose positron emission tomography (FDG-PET) in the management of…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Mutations within the tyrosine kinase domain of EGFR gene specifically occur in lung adenocarcinoma patients with a low exposure of tobacco smoking by SUGIO, K, URAMOTO, H, YASUMOTO, K, ONO, K, OYAMA, T, HANAGIRI, T, SUGAYA, M, ICHIKI, Y, SO, T, NAKATA, S, MORITA, M

    Published in British journal of cancer (27-03-2006)
    “…Somatically acquired mutations in the epidermal growth factor receptor (EGFR) gene in lung cancer are associated with significant clinical responses to…”
    Get full text
    Journal Article
  18. 18

    Serum adiponectin levels inversely correlate with the activity of progressive skin sclerosis in patients with diffuse cutaneous systemic sclerosis by Masui, Y., Asano, Y., Shibata, S., Noda, S., Aozasa, N., Akamata, K., Yamada, D., Tamaki, Z., Tada, Y., Sugaya, M., Sato, S., Kadono, T.

    “…Backgrounds  Adiponectin has been demonstrated to be one of anti‐inflammatory and anti‐fibrotic factors, suggesting the potential of this cytokine to be…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Serum lipocalin-2 levels are increased in patients with psoriasis by Kamata, M., Tada, Y., Tatsuta, A., Kawashima, T., Shibata, S., Mitsui, H., Asano, Y., Sugaya, M., Kadono, T., Kanda, N., Watanabe, S., Sato, S.

    Published in Clinical and experimental dermatology (01-04-2012)
    “…Summary The protein lipocalin (LCN)‐2 is known to be related to insulin resistance, obesity and atherosclerotic diseases. Psoriasis is an inflammatory skin…”
    Get full text
    Journal Article